Model
Edge
Intercept Pharmaceuticals, Inc.
0001606302
Filing Type
4
Filing Date
10/3/2017
Updated
10/4/17, 3:00 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership